logo
Select company
Select metric
Ticker Information

Ticker

BTMD

Company Name

BIOTE CORP

Sector

Healthcare

Industry

Medical Care Facilities

Exchange

NASDAQ

BIOTE CORP - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BTMD - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ -85.1M$ 31.31M0%
3/31/2025$ -89.98M$ 21.8M0%
12/31/2024$ -105.93M$ 3.16M0%
9/30/2024$ -130.34M$ 10.04M0%
6/30/2024$ -143.34M$ 6.87M0%
3/31/2024$ -35.4M$ 8.05M0%
12/31/2023$ -29.4M$ 3.32M0%
9/30/2023$ -40.53M$ -2.8M0%
6/30/2023$ -46.41M$ -10.31M0%
3/31/2023$ -48.54M$ -7.77M0%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BIOTE CORP's latest trailing twelve months (TTM) ROE stands at 0%.
  • Over the past 5 years, BIOTE CORP's average ROE has been 213.63%.
  • The median ROE for BIOTE CORP during this period was 213.63%
  • BIOTE CORP reached its highest ROE over the past 5 years at 427.25%.
  • The lowest ROE recorded by BIOTE CORP in the same timeframe 0%

BIOTE CORP's ROE vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROE Benchmarks
CompanyROE
PBYI : PUMA BIOTECHNOLOGY INC 46.27%AMWL : AMERICAN WELL CORP -44.06%INFU : INFUSYSTEM HOLDINGS INC 9.3%MGNX : MACROGENICS INC -78.08%JYNT : JOINT CORP -8.98%QIPT : QUIPT HOME MEDICAL CORP -10.01%AGEN : AGENUS INC -ATRA : ATARA BIOTHERAPEUTICS INC -CHRS : COHERUS ONCOLOGY INC 150.01%IRWD : IRONWOOD PHARMACEUTICALS INC -

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for BIOTE CORP is calculated as follows: Net Inc. Cmn. [ $ 0 ] / Equity [ $ 25K ]
(=) ROE [ 0% ]

BTMD - Return on Equity, Last 5 years

0%

Minimum

Dec 31, 2020

427.25%

Maximum

Mar 31, 2022

213.63%

Average

213.63%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.14K
min-66.79%
max73.25%
average1.51%
median6.45%
std22.67%